Video

Dr. Carlson on Treating Breast Cancer Patients Under 40

Grant W. Carlson, MD, professor of surgery, Emory University School of Medicine, chief, Division of Plastic Surgery, Emory University Hospital, discusses treating younger patients with breast cancer.

Grant W. Carlson, MD, professor of surgery, Emory University School of Medicine, chief, Division of Plastic Surgery, Emory University Hospital, discusses treating younger patients with breast cancer.

Carlson says patients who are younger than 40 years old make up 6-7% of all breast cancer patients in the United States. These patients tend to have more aggressive cancers and require systemic therapy and radiation therapy. Multivariate analysis shows that younger patients tend to do worse, Carlson says, because of the biology of the tumor.

Understanding tumor biology and the necessity for systemic and radiation therapy impacts local choices for a surgeon. Younger patients with breast cancer are unique with regard to psychological and social needs, marital status, desire to have children, and health, Carlson says. These patients are typically image conscious and will seek out breast reconstruction. Carlson says breast conservation is done in younger women but the aggressiveness of their disease often warrants a mastectomy.

Related Videos
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD
Vikram M. Narayan, MD
C. Ola Landgren, MD, PhD